Muse Cell Therapy Advances Webinar

[00:00:00]The company that we we interviewed, MuseCell Innovations, uh they acquired the core IP for this and they're now running trials and indications for stroke, spinal cord injury, and orthopedic repair, while obviously exploring where enriched MuseCell preparations could be used more proactively for tissue integrity and homeostasis as we age. If the early data hold up, MuseCells could finally deliver on some of the big promises of regenerative medicine. So, really excited about this. In fact, we're going to do a webinar uh next Monday. We're going to be doing this next generation of regenerative medicine with the cell MuseCells webinar, where we're going to really dig into the mechanisms, the trial data, and these practical pathways for clinicians and consumers to access these validated products rather than jumping into that kind of unregulated stem cell tourism.